Format

Send to

Choose Destination
Am Heart J. 1990 Mar;119(3 Pt 2):712-7; discussion 717.

Stratifying the patient at risk from coronary disease: new insights from the Framingham Heart Study.

Author information

1
Framingham Heart Study, MA 01701.

Abstract

Although cardiovascular disease remains the leading cause of death in the United States, cardiovascular disease mortality has decreased steadily during the past 2 decades. This trend is largely attributable to improved detection and management of cardiovascular risk factors, in which the Framingham Heart Study has played a major role. This article examines some of the risk factors associated with coronary heart disease, notably, advancing age, hypertension, left ventricular hypertrophy, smoking, elevated serum cholesterol, and reduced high-density lipoprotein, all of which have been investigated by the Framingham Heart Study. In addition, new data are presented from a multidimensional model of coronary heart disease. This is a novel approach that takes into account the interactions of multiple risk factors and their contribution to overall coronary heart disease risk.

PMID:
2137960
DOI:
10.1016/s0002-8703(05)80050-x
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center